标题
Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
作者
关键词
-
出版物
Cancers
Volume 15, Issue 21, Pages 5299
出版商
MDPI AG
发表日期
2023-11-06
DOI
10.3390/cancers15215299
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mRNA in the Context of Protein Replacement Therapy
- (2023) Theofanis Vavilis et al. Pharmaceutics
- Venous thromboembolism in viral diseases: A comprehensive literature review
- (2023) Nasibeh Zerangian et al. Health Science Reports
- Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review
- (2023) Qasem Al-Tashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
- (2023) Tong Li et al. SEMINARS IN CANCER BIOLOGY
- The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
- (2023) Mengyuan Li et al. Frontiers in Immunology
- Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma
- (2023) Locke J. Bryan et al. JAMA Oncology
- Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
- (2023) Bilal A Siddiqui et al. Journal for ImmunoTherapy of Cancer
- Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways
- (2023) Domenico Ribatti et al. Cancers
- The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy
- (2023) Roberto Tamma et al. Cancers
- Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis
- (2023) Haijiao Jing et al. Cancers
- Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
- (2023) Alessandro Cellini et al. Frontiers in Oncology
- The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy
- (2023) Kaushik Das et al. Biomolecules
- Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer
- (2023) Junyang Song et al. PATHOLOGY RESEARCH AND PRACTICE
- Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
- (2023) Devesh Aggarwal et al. Frontiers in Immunology
- The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
- (2023) Adrian Vasile Dumitru et al. Cells
- The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
- (2022) Jeremy A. Meier et al. Journal of Personalized Medicine
- A review of pathobiology and therapies for classic Hodgkin lymphoma
- (2022) Maliha Khan et al. BLOOD REVIEWS
- Vascular Permeability in Diseases
- (2022) Jean-Luc Wautier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
- (2022) Junjie Huang et al. Journal of Hematology & Oncology
- Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial
- (2022) Jessica Hochberg et al. Journal for ImmunoTherapy of Cancer
- The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good
- (2022) Victoria Menéndez et al. Cancers
- Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
- (2022) Alicia Cristina Peña-Romero et al. Cancers
- Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
- (2022) Marco Picardi et al. BRITISH JOURNAL OF HAEMATOLOGY
- AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial
- (2022) Stephanie Sasse et al. LEUKEMIA & LYMPHOMA
- Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
- (2022) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
- (2022) Shazia Nakhoda et al. Cancers
- Metabolism and polarization regulation of macrophages in the tumor microenvironment
- (2022) Jia Wang et al. CANCER LETTERS
- JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)
- (2022) Sarah Gillessen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Tumor-associated macrophages in lymphoma: From mechanisms to therapy
- (2022) Xingfang Xiong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
- (2022) Sharon M. Castellino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing the TME to improve the efficacy of cancer therapy
- (2022) Maria Teresa Bilotta et al. Frontiers in Immunology
- Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
- (2022) Mahdi Nohtani et al. Cancers
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
- (2022) Kun Cheng et al. Cancer Communications
- BCL-2 protein family: attractive targets for cancer therapy
- (2022) Deeksha Kaloni et al. APOPTOSIS
- Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
- (2022) Saimeng Shi et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
- (2022) Hamidreza Zalpoor et al. Cell Communication and Signaling
- The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis-associated lung injury
- (2022) Rong Yu et al. MOLECULAR IMMUNOLOGY
- Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
- (2022) Alex F Herrera et al. Lancet Haematology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular biology of Hodgkin lymphoma
- (2021) Marc A. Weniger et al. LEUKEMIA
- Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
- (2021) Rangarirai Makuku et al. Journal of Immunology Research
- Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
- (2021) Eline A. M. Zijtregtop et al. Cancers
- Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
- (2021) Suah Yang et al. BIOMATERIALS
- Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma
- (2021) Jan Filipiak et al. BLOOD COAGULATION & FIBRINOLYSIS
- Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: a comprehensive review
- (2021) Ke‐Tao Jin et al. CANCER SCIENCE
- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- (2021) Zheying Zhang et al. Frontiers in Immunology
- Molecular profiling of follicular fluid miRNAs in young women affected by Hodgkin Lymphoma
- (2021) Angela Caponnetto et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2021) Yuqin Song et al. Expert Review of Hematology
- The Role of Tumor-Associated Macrophages in Hematologic Malignancies
- (2021) Emanuele Cencini et al. Cancers
- Inflammation in Asthma Pathogenesis: Role of T cells, Macrophages, Epithelial Cells and Type 2 Inflammation
- (2021) Amina Alobaidi et al. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
- Preclinical pharmacology modeling of chimeric antigen receptor T therapies
- (2021) Rajendra Kumari et al. CURRENT OPINION IN PHARMACOLOGY
- Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma
- (2021) Maria A. Garcia-Marquez et al. LEUKEMIA
- Loss of function mutations of BCOR in classical Hodgkin lymphoma
- (2021) Maciej Giefing et al. LEUKEMIA & LYMPHOMA
- Immunotherapy for cancer: effects of iron oxide nanoparticles on polarization of tumor-associated macrophages
- (2021) Camila Sales Nascimento et al. Nanomedicine
- Author Correction: Hodgkin lymphoma
- (2021) Joseph M. Connors et al. Nature Reviews Disease Primers
- Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment
- (2021) Takashi Watanabe Cancers
- Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
- (2021) Artem Gusak et al. Cancers
- Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
- (2021) Timothy J. Voorhees et al. Blood Advances
- Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
- (2021) Pier Luigi Zinzani et al. Blood Advances
- Synthetic mRNA – emerging new class of drug for tissue regeneration
- (2021) Elizabeth Rosado Balmayor CURRENT OPINION IN BIOTECHNOLOGY
- A Novel Cytological Model of B-Cell/Macrophage Biphenotypic Cell Hodgkin Lymphoma in Ganp-Transgenic Mice
- (2020) Sakai et al. Cancers
- Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
- (2020) Brooke Benner et al. Drug Design Development and Therapy
- Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
- (2020) Kristiina Karihtala et al. Cancers
- Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
- (2020) Carlos A. Ramos et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
- (2020) Laura Werner et al. Scientific Reports
- Regulation of glycolysis by the hypoxia‐inducible factor (HIF): implications for cellular physiology
- (2020) S. J. Kierans et al. JOURNAL OF PHYSIOLOGY-LONDON
- Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
- (2020) Lutz Menzel et al. Frontiers in Immunology
- Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
- (2020) Naike Casagrande et al. CANCER LETTERS
- Tumor-associated macrophages: role in cancer development and therapeutic implications
- (2019) Arash Salmaninejad et al. CELLULAR ONCOLOGY
- Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation
- (2019) Haitham Abdelhakim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma
- (2019) Paul G. Murray et al. BLOOD
- Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma
- (2019) Junko Yamaguchi et al. LEUKEMIA & LYMPHOMA
- Cancer and the Immune System: The History and Background of Immunotherapy
- (2019) Maura Abbott et al. Seminars in Oncology Nursing
- Immune modulation by mesenchymal stem cells
- (2019) Wei Jiang et al. CELL PROLIFERATION
- Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
- (2019) Eleonora Calabretta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology and Etiology of Leukemia and Lymphoma
- (2019) Jordan A. Baeker Bispo et al. Cold Spring Harbor Perspectives in Medicine
- Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
- (2019) Amy J. Petty et al. Cells
- Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
- (2019) Chenggong Li et al. Briefings in Functional Genomics
- Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma
- (2019) Johanna Veldman et al. CANCER TREATMENT REVIEWS
- Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors
- (2019) Yoshie Kametani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
- (2018) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling
- (2018) Liang Luo et al. Biomed Research International
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Microenvironment Cell Contribution to Lymphoma Immunity
- (2018) Deepika Kumar et al. Frontiers in Oncology
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
- (2017) Carlos A. Ramos et al. JOURNAL OF CLINICAL INVESTIGATION
- Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
- (2017) Sagun Goyal et al. LEUKEMIA & LYMPHOMA
- Role of the tumor microenvironment in regulating apoptosis and cancer progression
- (2016) Katherine Yaacoub et al. CANCER LETTERS
- Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
- (2016) Donatella Aldinucci et al. CANCER LETTERS
- The Future of Vascular Biology and Medicine
- (2016) Scott Kinlay et al. CIRCULATION
- Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial
- (2016) Chun-Meng Wang et al. CLINICAL CANCER RESEARCH
- Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
- (2016) Amos Kirilovsky et al. INTERNATIONAL IMMUNOLOGY
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reed-Sternberg cell-derived lymphotoxin- activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma
- (2014) C. W. Fhu et al. BLOOD
- Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
- (2014) J. Reichel et al. BLOOD
- Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
- (2014) K. Kushekhar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Epstein-Barr virus and the pathogenesis of lymphoma
- (2014) Martina Vockerodt et al. JOURNAL OF PATHOLOGY
- The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
- (2014) Y Liu et al. LEUKEMIA
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- Immunologic pathomechanism of Hodgkin's lymphoma
- (2013) Adam Jona et al. EXPERIMENTAL HEMATOLOGY
- The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component
- (2013) Yuxuan Liu et al. SEMINARS IN CANCER BIOLOGY
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Pilot study of vascular health in survivors of Hodgkin lymphoma
- (2012) Daniel A. Mulrooney et al. PEDIATRIC BLOOD & CANCER
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- TNF superfamily in inflammatory disease: translating basic insights
- (2011) Michael Croft et al. TRENDS IN IMMUNOLOGY
- Tumor Necrosis Factor (TNF) and Lymphotoxin- (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
- (2010) C. F. Skibola et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Multiplexed Detection and Characterization of Rare Tumor Cells in Hodgkin’s Lymphoma with Multicolor Quantum Dots
- (2010) Jian Liu et al. ANALYTICAL CHEMISTRY
- Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
- (2010) C. Steidl et al. BLOOD
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma
- (2009) Roland Schmitz et al. Annual Review of Pathology-Mechanisms of Disease
- IL-21: roles in immunopathology and cancer therapy
- (2009) H. Søndergaard et al. TISSUE ANTIGENS
- Expression and function of T cell homing molecules in Hodgkin’s lymphoma
- (2008) Lee Machado et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
- (2008) Maura O'Leary et al. SEMINARS IN ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started